Catalyst Watch: Jobs report, new Apple products, and a spotlight on software
Source: SeekingAlpha
2026-02-27 15:00:32 ET
More on the markets
- Fed Rate Cuts On Hold, But Liquidity Conditions Still Look Supportive For Stocks
- They Said Stocks Would Only Return 6%, They Were Wrong
- Follow Rates Of Change To Be Ahead Of The Curve In 2026
- Private credit default risk in software could top 15%, warns Marathon’s Bruce Richards: BBG interview
- SA Analyst says market rotation deepens as Nvidia slides
Read the full article on Seeking Alpha
For further details see:
Catalyst Watch: Jobs report, new Apple products, and a spotlight on software
Xenon Pharmaceuticals Inc.
NASDAQ: XENE
XENE Trading
49.43% G/L:
$62.05 Last:
8,324,258 Volume:
$60.56 Open:
XENE Latest News
March 09, 2026 07:00:00 am
Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)
March 08, 2026 02:00:00 pm
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
February 26, 2026 04:01:00 pm
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
XENE Stock Data
$3,288,437,838
74,129,912
0.74%
73
N/A
Biotechnology & Life Sciences
Healthcare
CA
Burnaby
